Jump to ContentJump to Main Navigation

Online

149,00 € / $224.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
August 2011
ISSN:
2191-0251
DOI:
10.1515/jpem.2011.257

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 149.00
RRP for USA, Canada, Mexico
US$ 224.00 *
Print
Individual Subscription Online only
Euro [D] 873.00
RRP for USA, Canada, Mexico
US$ 1310.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1048.00
RRP for USA, Canada, Mexico
US$ 1572.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Editor-in-Chief: Zadik, Zvi

Editorial Board Member: Cassorla, Fernando / Cutfield, Wayne / de Muinck Keizer-Schrama, Sabine M.P.F. / Fideleff, Hugo L. / LaFranch, Stephen H. / Lanes M. D., Roberto / Levitsky, Lynne / Lippe, Barbara / Pfäffle, Roland / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Kiess, Wieland

12 Issues per year

IMPACT FACTOR 2011: 0.875
5-year IMPACT FACTOR: 1.026

VolumeIssuePage

Issues

Graves’ disease in a Down’s syndrome patient responds well to radioiodine rather than antithyroid drugs

1 / Kalpajyoti Das1 / Chandrasekhar Bal1

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

Corresponding author: Nishikant A. Damle, MD, Room no. 59 A, Department of Nuclear Medicine, A.I.I.M.S, New Delhi-110029, India Phone: +91-11-26593210, Fax: +91-11-26588663

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 7-8, Pages 611–611, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem.2011.257, August 2011

No abstract available

Keywords: antithyroid drugs; Down’s syndrome; Graves’ disease; radioiodine

Comments (0)

Please log in or register to comment.